Search - tctmd.com

Displaying 1 - 20 of 317

Sort: Relevancy | Date

News Daily News

Coronary DCB Works Well in Multilayer In-Stent Restenosis: AGENT IDE Subanalysis

L.A. McKeown

August 12, 2025

News Daily News

Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3

Yael L. Maxwell

January 15, 2025

News Daily News

Top Coronary Artery Disease News in 2024

Michael O'Riordan

December 26, 2024

News Daily News

DES Best for In-Stent Restenosis, but DCBs Also Viable

Michael O'Riordan

August 13, 2024

News Daily News

FDA Approves Bioresorbable Scaffold for BTK Lesions

Michael O'Riordan

April 29, 2024

News Daily News

DCB in STEMI Match DES Through 5 Years: REVELATION

Caitlin E. Cox

March 27, 2024

News Daily News

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

L.A. McKeown

March 25, 2024

News Daily News

TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable

Michael O'Riordan

January 09, 2024

News Daily News

IVUS in Complex PCI Improves Outcomes, Even for Less-Experienced Operators

Caitlin E. Cox

July 27, 2023

News Daily News

Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis

Michael O'Riordan

February 24, 2023

News Daily News

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

L.A. McKeown

January 24, 2023

News Daily News

Brachytherapy Remains an Option for DES In-Stent Restenosis

Yael L. Maxwell

January 12, 2023

News Daily News

High Lp(a) May Predict Risk of CV and Limb Events in PAD

L.A. McKeown

July 18, 2022

News Daily News

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

Michael O'Riordan

March 30, 2022

News Daily News

IVUS-Guided PCI Tied to Better Long-term Outcomes After Acute MI

Todd Neale

October 29, 2021

News Daily News

Cardiac Deaths and Adverse Events After PCI Have Declined With Time

L.A. McKeown

October 05, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for September 2021

Shelley Wood

October 01, 2021

News Daily News

DCB Match DES for Treating Coronary In-Stent Restenosis: European Registry

Caitlin E. Cox

September 15, 2021

News Daily News

DCB in Diabetes Show Promising Long-term Outcomes: BASKET-SMALL 2

L.A. McKeown

August 16, 2021

News Daily News

FDA Permits 28-Day DAPT in Xience-Treated Patients at High Bleeding Risk

Michael O'Riordan

June 30, 2021

Advertisement

Coronary DCB Works Well in Multilayer In-Stent Restenosis: AGENT IDE Subanalysis

Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3

Top Coronary Artery Disease News in 2024

DES Best for In-Stent Restenosis, but DCBs Also Viable

FDA Approves Bioresorbable Scaffold for BTK Lesions

DCB in STEMI Match DES Through 5 Years: REVELATION

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable

IVUS in Complex PCI Improves Outcomes, Even for Less-Experienced Operators

Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

Brachytherapy Remains an Option for DES In-Stent Restenosis

High Lp(a) May Predict Risk of CV and Limb Events in PAD

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

IVUS-Guided PCI Tied to Better Long-term Outcomes After Acute MI

Cardiac Deaths and Adverse Events After PCI Have Declined With Time

TCTMD’s Top 10 Most Popular Stories for September 2021

DCB Match DES for Treating Coronary In-Stent Restenosis: European Registry

DCB in Diabetes Show Promising Long-term Outcomes: BASKET-SMALL 2

FDA Permits 28-Day DAPT in Xience-Treated Patients at High Bleeding Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content